Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data

Recently, guidelines for endometrial cancer (EC) were released that guide treatment decisions according to the tumors’ molecular profiles. To date, no real-world data regarding the clinical feasibility of molecular profiling have been released. This retrospective, monocentric study investigated the...

Full description

Bibliographic Details
Main Authors: Felicitas Oberndorfer, Sarah Moling, Leonie Annika Hagelkruys, Christoph Grimm, Stephan Polterauer, Alina Sturdza, Stefanie Aust, Alexander Reinthaller, Leonhard Müllauer, Richard Schwameis
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Personalized Medicine
Subjects:
endometrial cancer
cancer gene panel sequencing
molecular tumor classification
Online Access:https://www.mdpi.com/2075-4426/11/1/48

Internet

https://www.mdpi.com/2075-4426/11/1/48

Similar Items